Executioner caspase-3 and caspase-7 are functionally distinct proteases

Caspase 7 Proteomics 0301 basic medicine Cell-Free System Proteome Caspase 3 Hydrolysis Molecular Sequence Data Caspase 9 Recombinant Proteins Intramolecular Oxidoreductases Jurkat Cells Mice 03 medical and health sciences Cell Line, Tumor Animals Cytochromes Humans Amino Acid Sequence Protein Processing, Post-Translational BH3 Interacting Domain Death Agonist Protein Prostaglandin-E Synthases
DOI: 10.1073/pnas.0707715105 Publication Date: 2008-08-23T00:54:42Z
ABSTRACT
Members of the caspase family of cysteine proteases play central roles in coordinating the stereotypical events that occur during apoptosis. Because the major executioner caspases, caspase-3 and caspase-7, exhibit almost indistinguishable activity toward certain synthetic peptide substrates, this has led to the widespread view that these proteases occupy functionally redundant roles within the cell death machinery. However, the distinct phenotypes of mice deficient in either of these caspases, as well as mice deficient in both, is at odds with this view. These distinct phenotypes could be related to differences in the relative expression levels of caspase-3 and caspase-7 in vivo , or due to more fundamental differences between these proteases in terms of their ability to cleave natural substrates. Here we show that caspase-3 and caspase-7 exhibit differential activity toward multiple substrate proteins, including Bid, XIAP, gelsolin, caspase-6, and cochaperone p23. Caspase-3 was found to be generally more promiscuous than caspase-7 and appears to be the major executioner caspase during the demolition phase of apoptosis. Our observations provide a molecular basis for the different phenotypes seen in mice lacking either caspase and indicate that these proteases occupy nonredundant roles within the cell death machinery.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (17)
CITATIONS (483)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....